The Acute Ischemic Stroke Market to Grow Positively at a significant CAGR During the Study Period (2019-2032), estimates DelveInsight

 Breaking News
  • No posts were found

The Acute Ischemic Stroke Market to Grow Positively at a significant CAGR During the Study Period (2019-2032), estimates DelveInsight

February 08
20:50 2023
The Acute Ischemic Stroke Market to Grow Positively at a significant CAGR During the Study Period (2019-2032), estimates DelveInsight

DelveInsight’s Acute Ischemic Stroke Market Insight, Epidemiology and Market Forecast 2032 report provides current treatment practices, emerging drugs, Acute Ischemic Stroke market share of the individual therapies, current and forecasted Acute Ischemic Stroke market size from 2019 to 2032 segmented by seven major markets. The report also offers current Acute Ischemic Stroke therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute Ischemic Stroke market.


Acute Ischemic Stroke Overview

Acute Ischemic Stroke (AIS) occurs when blood flow through a brain artery is blocked by a clot- a mass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop within the body. A thrombotic stroke, more common of the two, occurs when a clot forms within an artery in the brain. An embolic stroke occurs when a clot or small piece of plaque (fatty deposit) breaks off from elsewhere in the body, such as the heart, and travels through the bloodstream only to become stuck in a narrower vessel in the brain.

Almost half of all acute ischemic strokes are due to large vessel occlusion (LVO). An LVO is the most severe and debilitating type of stroke as the clot occludes major arteries and prevents blood flow to significant portions of the brain. Ischemic stroke is also more common in people who have a family history of stroke or who’ve had past strokes. Men are more likely than women to have ischemic stroke, while blacks have a higher risk than other races or ethnic groups. Risk also increases with age.

Symptoms of stroke depend on severity and location of stroke in the brain. Some people do not experience any symptoms while others experience may experience only one. Most people, however, experience a combination of symptoms. Symptoms may include paralysis on one side of the body, dizziness or loss of balance, problems with eyesight etc.


Acute Ischemic Stroke Epidemiological Insights

According to the World Health Organization (WHO), an estimated 15 million individuals worldwide suffer from stroke each year. Of these, 5 million die, and another 5 million are left permanently disabled.


Acute Ischemic Stroke Treatment Market 

The therapeutic market for the treatment of Acute Ischemic Stroke (AIS) can be primarily divided into two main categories based on their mechanism of action: thrombolytics and neuroprotective agents. Thrombolytic therapy aims at removing the thrombus blockage and includes drugs that act as recombinant tissue plasminogen activators (rt-PA), antithrombotic agents and platelet aggregation inhibitors. On the other hand, neuroprotective agents act by various mechanisms and are subsequently classified based on their mechanism of action antioxidants, neuron stimulants, calcium channel antagonists and free radical scavengers. Current treatment of AIS is based on the restoration of blood flow to the brain by thrombolysis. Additionally, Activase (Genentech) is approved therapy for the treatment of Acute Ischemic Stroke.


Promising Therapies in the Acute Ischemic Stroke Pipeline

  • MultiStem
  • BMS-986177
  • LT-3001
  • Elezanumab
  • And others


Discover more about Acute Ischemic Stroke therapies in the pipeline @ Acute Ischemic Stroke Drugs


Leading Companies Working in the Acute Ischemic Stroke Market

  • Athersys/Healios K.K.
  • Bristol-Myers Squibb
  • Lumosa Therapeutics
  • And others


To understand key companies related to the Acute Ischemic Stroke Market, get a snapshot of the Acute Ischemic Stroke Regulatory and Patent Analysis.


Scope of the Acute Ischemic Stroke Market Report

Study Period: 2019–2032

Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]

Key Acute Ischemic Stroke Companies: Athersys/Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics, and others

Key Acute Ischemic Stroke Pipeline Therapies: MultiStem, BMS-986177, LT-3001, Elezanumab, and others

Therapeutic Assessment: Acute Ischemic Stroke current marketed and emerging therapies

Acute Ischemic Stroke Market Dynamics: Acute Ischemic Stroke market drivers and barriers 

Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

Unmet Needs, KOL’s views, Analyst’s views, Acute Ischemic Stroke Market Access and Reimbursement


Table of Contents

1. Acute Ischemic Stroke Market Key Insights

2. Acute Ischemic Stroke Market Report Introduction

3. Acute Ischemic Stroke Market Overview at a Glance

4. Acute Ischemic Stroke Market Executive Summary

5. Disease Background and Overview

6. Acute Ischemic Stroke Treatment and Management

7. Acute Ischemic Stroke Epidemiology and Patient Population

8. Patient Journey

9. Acute Ischemic Stroke Emerging Drugs

10. 7MM Acute Ischemic Stroke Market Analysis

11. Acute Ischemic Stroke Market Outlook

12. Potential of Current and Emerging Therapies

13. KOL Views

14. Acute Ischemic Stroke Market Drivers

15. Acute Ischemic Stroke Market Barriers

16. Unmet Needs

17. SWOT Analysis

18. Appendix

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Trending Report Offerings by DelveInsight:

  • Gender Dysphoria Market
  • Germany Healthcare Outlook Market
  • Hyperlipidemia Market
  • Mammography Devices Market
  • Dental Equipment Market
  • Adalimumab Biosimilar Market
  • Medical Marijuana Market
  • Hyperlipidemia Market
  • Metastatic Cutaneous Squamous Cell Cancer Market
  • Mucopolysaccharidosis Market


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.


Contact Us

Kritika Rehani

[email protected] 


Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States